Test Details
Include test name, CPT/LOINC codes, specimen ID and collection date, assay platform, and lot/control identifiers so reviewers can map results to the correct laboratory procedure and billing codes.
A standardized Healthcare Molecular Attestation Form reduces ambiguity, creates an auditable trail, and clarifies responsibility for test results. It supports payer documentation, regulatory audits, and clinical governance while aligning with HIPAA safeguards and common record-retention expectations.
Common users include laboratories, ordering clinicians, hospitals, and insurers who require verifiable molecular test attestations for patient care and billing.
Each stakeholder relies on consistent attestation fields to support audits, appeals, public health reporting, and continuity of clinical care.
The laboratory director or authorized designee reviews assay performance data, certifies quality control compliance, and signs the attestation. Their credentials and license must be recorded to attribute responsibility and meet accreditation and payer documentation standards.
The ordering clinician confirms specimen collection details, receives and documents results interpretation, and may co-sign or acknowledge the attestation when required by institutional policy. Clinician identifiers and contact information support clinical follow-up and liability attribution.
Include test name, CPT/LOINC codes, specimen ID and collection date, assay platform, and lot/control identifiers so reviewers can map results to the correct laboratory procedure and billing codes.
Describe assay technique (PCR, sequencing, other), validation status, sensitivity/specificity where applicable, and references to protocols or EUA/510(k) authorization to support clinical interpretation and regulatory review.
Document internal controls, external proficiency testing results, calibration dates, and corrective actions taken for any nonconformities to demonstrate testing reliability and accreditation compliance and traceability records.
Provide numeric results, qualitative calls, reference ranges, interpretive comments, and any limitations or follow-up recommendations, including suggested confirmatory testing when appropriate.
Specify signer name, title, institution, credential numbers, contact information, signature, and date to attribute responsibility and satisfy audit and payer documentation requirements, including licensure state.
Attach supporting lab reports, chain-of-custody logs, instrument prints, batch certificates, and any patient or institutional consent forms required for disclosure or secondary use, and payer-specific documentation.
| Field | Configuration |
|---|---|
| Auto-Fill | Enable Magic fields to detect patient details |
| Conditional Sections | Show QC fields only when failed controls present |
| Signer Authentication | SMS code or KBA for external signers |
| Audit Trail | Capture IP, timestamp, and action log |
| Retention Settings | Set storage period per HIPAA and state law |
Digital signing and eSubmission require platform support for secure storage, audit trails, HIPAA compliance, and common document formats.
Date/time recorded at collection; affects validity window.
Result timeframe varies by assay—document expected TAT.
Claims require attestation with initial claim or appeal.
Reportable results must be submitted per state rules.
Retention period starts on report release date.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day trial | Varies | Varies | Varies | Varies |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No cap | 100 envelopes/user/year | Varies | Varies | Varies |
Fertility Centers of Illinois moved to electronic attestations to accelerate patient reporting while keeping records audit-ready and HIPAA-compliant.
Optica Ventures implemented standardized attestation forms for outsourced molecular testing to reduce ambiguity and accelerate contract fulfillment across multiple partners.